MANA RBM's network of clinical researchers reported that research sites are eliminating onsite monitoring visits. If onsite monitoring visits are a Sponsor's main oversight approach, the solution to this critical problem is available now.
MANA RBM provides remote, automated risk-based monitoring (RBM) customized to a site's protocol. The company delivers its solution, customized to the areas of greatest concern, specific to a study. Subject review can begin within days.
"We recently published an example of this successful approach, adding remote Risk Based Monitoring to trials being conducted with traditional SDV," said Penny Manasco, M.D., CEO of MANA RBM. "Within days, we started remote subject review. Within 2 months, we identified critical errors that SDV did not find."
Here is the link to the head to head comparison:
http://www.appliedclinicaltrialsonline.com/comparing-risk-based-monitoring-and-remote-trial-management-vs-sdv
March 17, 2020
Topic Area: Press Release
Recent Posts
The Future of the Global Hospital Hygiene Market
A market study details the current state of the global hygiene market and the factors that are expected to make a big difference in the next decade.
Rethinking Fire Safety Inspections
Digital tools bridge the gap between growing facility complexity and workforce limitations, allowing teams to maintain the highest safety standards.
The Ohio State University Wexner Medical Center Officially Opens
With the new hospital comes other changes, including new street and building names on the medical campus.
Healthcare and Resilience: A Pledge for Change
Climate resilience and reducing environmental impact drive voluntary program targeting hospitals.
Texas Health Resources Announces New Hospital for North McKinney
Expected to open in 2028, the hospital will feature 60 beds initially with plans to double in capacity to accommodate for future community growth.